Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 92, Issue 5, Pages 613-621Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2012.102
Keywords
-
Categories
Ask authors/readers for more resources
Transforming growth factor-beta (TGF-beta) influences the development of myocardiopathy in Chagas disease through regulation of (i) parasite invasion of heart cells, (ii) an intracellular parasite cycle, (iii) inflammation and immune response, (iv) heart fibrosis and remodeling, and (v) gap junction modulation and heart conduction. In this review, we discuss the rationale for developing TGF-beta signaling-interfering therapies as adjuvant approaches for the management of the cardiac alterations of Chagas disease-affected patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available